Transplants of unrelated cord blood or sibling allogeneic peripheral blood stem cells/bone marrow in adolescent and young adults with chronic myeloid leukemia: comparable outcomes but better chronic GVHD-free and relapse-free survival among survivors with cord blood

Adolescent and young adult (AYA) patients with hematological malignancy aged 15 to 39 years are recognized as a separate entity, and the efficacy and safety of unrelated cord blood transplantation (CBT) for chronic myeloid leukemia (CML) in AYA patients has not been reported. From March 2002 to June...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Changcheng, Zhu, Xiaoyu, Tang, Baolin, Zhang, Xuhan, Zhang, Lei, Geng, Liangquan, Liu, Huilan, Sun, Zimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788685/
https://www.ncbi.nlm.nih.gov/pubmed/29416817
http://dx.doi.org/10.18632/oncotarget.22979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788685/
https://www.ncbi.nlm.nih.gov/pubmed/29416817
http://dx.doi.org/10.18632/oncotarget.22979

Ejemplares similares